Arch Therapeutics Inc (ARTH)

[Polyphemus]

Response to Blackgold: By fundamentals, I meant company financial projections, operational accomplishments to date, etc. in this case. There is a history at ARTH of failure to hit projected project milestones. The compensation data and bio info to which I referred was directly taklen from the company's 10K statements filed with the SEC. Perhaps you can look this up for yourself. You are correct to dismiss reports based upon data and opinions found only on the internet. These could be fabricated by self-interetsed individuals.

I am aware of the published MIT reports of in vivo studies. For those who care: one of the MIT publications stated that the researchers could not identify or find a mechanism for the reported hemostatic effect, but felt that it was not due to the material acting as a sealant in a small wound. Importantly, the authors stated that they could not find any evidence of the presence of platelets at the wound site. Hemostasis does not occur without the presences and activity of platelets, though tissue sealing does. See for yourself. This has implicatiuons for the types of devices that could be successfully developed eiththis technology.

I have chosen to not invest.